Albumin nanoparticles with predictable size by desolvation procedure

References

• Arnold K, Herrmann A, Pratsch L, Gawrisch K. The dielectric properties of aqueous solutions of poly(ethylene glycol) and their influence on membrane structure. Biochim Biophys Acta 1985; 815: 515–18
   PubMed Web of Science ®Google Scholar
• Bootz A, Vogel V, Schubert D, Kreuter J. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 2004; 57: 369–75
   PubMed Web of Science ®Google Scholar
• Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994; 45: 153–203
   PubMedGoogle Scholar
• Coester CJ, Langer K, van Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation – A new preparation method, surface modifications and cell uptake. J Microencapsulation 2000; 17: 187–93
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008; 29: 1912–19
   PubMed Web of Science ®Google Scholar
• Dejaeger N, Demeyere H, Finsy R, Sneyers R, Vanderdeelen J, Vandermeeren P, Vanlaethem M. Particle sizing by photon-correlation spectroscopy. Part I: Monodisperse lattices: Influence of scattering angle and concentration of dispersed material. Part Part Syst Char 1991; 8: 179–86
   Web of Science ®Google Scholar
• Eppler A, Weigandt M, Hanefeld A, Bunjes H. Relevant shaking stress conditions for antibody preformulation development. Eur J Pharm Biopharm 2010; 74: 139–47
   PubMed Web of Science ®Google Scholar
• Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution. Int J Pharm 2008; 349: 249–55
   PubMed Web of Science ®Google Scholar
• Finsy R, Dejaeger N. Particle sizing by photon-correlation spectroscopy. Part II: Average values. Part Part Syst Char 1991; 8: 187–93
   Web of Science ®Google Scholar
• Finsy R, Dejaeger N, Sneyers R, Gelade E. Particle sizing by photon-correlation spectroscopy. Part III: Mono and bimodal distributions and data-analysis. Part Part Syst Char 1992; 9: 125–37
   Web of Science ®Google Scholar
• Finsy R, Deriemaeker L, Dejaeger N, Sneyers R, Vanderdeelen J, Vandermeeren P, Demeyere H, Stonemasui J, Haestier A, Clauwaert J, et al. Particle sizing by photon-correlation spectroscopy. Part IV: Resolution of bimodals and comparison with other particle sizing methods. Part Part Syst Char 1993; 10: 118–28
   Web of Science ®Google Scholar
• Fu Q, Sun J, Zhang W, Sui X, Yan Z, He Z. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 2009; 4: 262–72
   PubMed Web of Science ®Google Scholar
• Habeeb AJ, Hiramoto R. Reaction of proteins with glutaraldehyde. Arch Biochem Biophys 1968; 126: 16–26
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 1990; 42: 821–6
   PubMed Web of Science ®Google Scholar
• Kiese S, Papppenberger A, Friess W, Mahler HC. Shaken, not stirred: Mechanical stress testing of an IgG1 antibody. J Pharm Sci 2008; 97: 4347–66
   PubMed Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 2003; 257: 169–80
   PubMed Web of Science ®Google Scholar
• Li L, Zhao X, Yang C, Hu H, Qiao M, Chen D. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology. Drug Dev Ind Pharm 2011; 37(10)1170–80
   PubMed Web of Science ®Google Scholar
• Lin W, Coombes AG, Davies MC, Davis SS, Illum L. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target 1993; 1: 237–43
   PubMed Web of Science ®Google Scholar
• Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: Pathways, induction factors and analysis. J Pharm Sci 2009; 98: 2909–34
   PubMed Web of Science ®Google Scholar
• Michaelis K, Hoffmann MM, Dreis S, Herbert E, Alyautdin RN, Michaelis M, Kreuter J, Langer K. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006; 317: 1246–53
   PubMed Web of Science ®Google Scholar
• Miele E, Spinelli GP, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomed 2009; 4: 99–105
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001; 53: 283–318
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Rajabi-Siahboomi AR. Recent advances in cellular, sub-cellular and molecular targeting. Adv Drug Delivery Rev 2000; 41: 129–33
   PubMed Web of Science ®Google Scholar
• Preuss A, Chen K, Hackbarth S, Wacker M, Langer K, Roder B. Photosensitizer loaded HSA nanoparticles II: In vitro investigations. Int J Pharm 2011; 404: 308–16
   PubMed Web of Science ®Google Scholar
• Scopes RK. Protein purification: Priciples and practice, 3rd. Springer-Verlag, New York 1994
   Google Scholar
• Steinhauser I, Spankuch B, Strebhardt K, Langer K. Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells. Biomaterials 2006; 27: 4975–83
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007; 9: E128–47
   PubMed Web of Science ®Google Scholar
• Wacker M, Chen K, Preuss A, Possemeyer K, Roeder B, Langer K. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. Int J Pharm 2010; 393: 253–62
   PubMed Web of Science ®Google Scholar
• Wacker M, Zensi A, Kufleitner J, Ruff A, Schutz J, Stockburger T, Marstaller T, Vogel V. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation. Int J Pharm 2011; 414: 225–32
   PubMed Web of Science ®Google Scholar
• Wartlick H, Spankuch-Schmitt B, Strebhardt K, Kreuter J, Langer K. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J Controlled Release 2004; 96: 483–95
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 2000a; 194: 91–102
   PubMed Web of Science ®Google Scholar
• Weber C, Reiss S, Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int J Pharm 2000b; 211: 67–78
   PubMed Web of Science ®Google Scholar
• Westcott CC. pH Measurements. Academic Press, New York 1978
   Google Scholar